Kristin M. Nevins, Principal

Intellectual Property (IP) And Patent Law

Email:	knevins@offitkurman.com
Office Phone:	267.338.1305
Fax:	267.338.1335
Mailing Address:	Ten Penn Center 1801 Market Street Suite 2300 Philadelphia, PA 19103
Download vCard:	vCard

Practice Areas

Practice Focus

Kristin Mazany Nevins is a member of Offit Kurman's Intellectual Property (IP) Practice Group. Ms. Nevins is a registered patent attorney and focuses her practice on patent prosecution, enforcement, agreements and due diligence surrounding patent business transactions as well as other IP work, including trademark matters.

Education

• J.D., Temple University - James E. Beasley School of Law, 2003
• M.S., Biomedical Chemistry, Thomas Jefferson University, 2000
• B.S., Biochemistry, Lyman Briggs School of Michigan State University, 1992

Bar and Court Admissions

• Pennsylvania
• United States District Court for the Eastern District of Pennsylvania
• Patent Bar (Federal Reg. No. 56,775)

Activities

Kristin presently serves on the Executive Council of the Agnes Irwin School; is a member and past-Chair of the Women’s Committee for Laurel House; Board Member of the Philadelphia Skating Club and Human Society (2010-2012); and is the 2012-2013 Chair of the 166th & 167th Annual St. David’s Fair and Auction. Kristin is also a member of the American Intellectual Property Law Association, and is active with the FDA & Medical Devices sub-committee. She is a member of the Philadelphia Volunteer Lawyers for the Arts, and is a member of and evaluator for the Life Sciences Futures 2013 Scientific Presentations sub-Committee

Previous Work

Prior to joining Offit Kurman, Ms. Nevins was an attorney at a regional full-service law firm, where her representative clients included major pharmaceutical companies, universities and technology companies.

Speeches/Publications

• Medical Devices: Innovation, Regulations and Commercialization.
  Presented to the pharmaceutical product development program at West Chester University, Fall Semester 2013.
• Mazany Nevins, K., Pay to Play: What Property Management companies need to know about playing copyrighted music in common areas of buildings, The Bulletin, Vol. 41, No. 7, August 2013.
• Mazany Nevins, K., Best Business Practices for Protecting Innovation and Staying Competitive
  in a New Patent Landscape, Journal of the Maryland Association of CPAs, April 2013.
• Creating an IP Culture within your Corporation: Strategies and Best Practices.
  Presented to the Delaware Valley Association of Corporate Counsel, February 2013.
• Mazany, K.D., Williams, K.J. Genetic manipulation of arterial matrix in vivo substantially alters the development of early atherosclerosis: The decorin null mouse. (Presented by Kristin at the 73rd Scientific Sessions of the American Heart Association, New Orleans, Louisiana, November 2000)
• Fuki, I.V., Mazany, K.D., Williams, K.J. Molecular determinants of syndecan-mediated endocytosis, a novel, multi-step pathway independent of coated pits. (Presented at the 72nd Scientific Sessions of the American Heart Association, Atlanta, GA November 1999)
• Williams, K.J., Scalia, R.G., Mazany, K.D., Rodriqueza, W.V., and Lefer, A.M. Rapid Restoration of normal endothelial functions by forcing reverse cholesterol transport in vivo. Arteriosclerosis, Thrombosis and Vascular Biology, 20 (2000) 1033-1039.
• Mazany, K.D., Peng, T., Tabas, I., and Williams, K.J. Human chondroitin 6-sulfotransferase: cloning, gene structure, and chromosomal localization. Biochemica et Biophysica Acta. 1409 (1998) 92-97.
• Scalia, R.G., Rodriqueza, W.V., Mazany, K.D., and Lefer, A.M, Williams, K.J., Large Unilamellar Phospholipid Vesicles Accelerate Reverse Lipid Transport and Normalize Endothelial Function in Hyperlipidemic Apo-E Knock-out Mice. Circulation 98 (1998) I-732. (Presented at the 71st Scientific Sessions of the American Heart Association, Dallas, TX)
• Rodrigueza, W.V., Mazany, K.D., Essenburg, A.E., Pape, M.E., Bisgaier, C.L. and Williams, K.J. Large versus small unilamellar vesicles mediate reverse cholesterol transport in vivo into two distinct metabolic pools: implications for the treatment of atherosclerosis. Arteriosclerosis, Thrombosis and Vascular Biology. 17 (1997) 2132-2139. (Also presented at the 68th Scientific Sessions of the American Heart Association, Anaheim, CA)